AzTrials
AzTrials

Low Back PainNCT05215093

The Direct-Physio Trial

A study testing Direct access physiotherapy for acute low back pain in people with Low Back Pain and Physiotherapy, run by Hasselt University at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Previous research showed that direct access to physiotherapy, and the associated early physiotherapeutic treatment of patients with low back pain (LBP), results in improved clinical outcomes, as well as reduced health-related costs. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Low Back Pain, Physiotherapy
What is being tested?
Direct access physiotherapy for acute low back pain
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteBelgium
Study dates
1 Dec 2022to 1 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients with non-specific acute LBP defined as (based on Nicol et al. 2020):
  • pain between the 12th rib and buttocks
  • associated or not with non-dominant leg pain
  • looking for LBP care for the first time in case of first episode, OR for the first time for the current episode in case of recurrent or persistent LBP
  • lasting > 24 hours and < 6 weeks
  • with an average pain intensity during the past 24 hours of ≥ 3 on an 11-point Numerical Pain Rating Scale
  • with an Oswestry Disability Index score (version 2.1a) of at least 20% (Denteneer et al. 2018).
  • Patients aged between 18 and 65 years

Who cannot join

  • Recent lumbar surgery (< 1 year)
  • Pregnancy
  • History of (any) treatment for the current pain episode
  • Red flags suggesting specific LBP (e.g. resulting from infection or neoplasm, cauda equina), based on the Belgian Health Care Knowledge Center (KCE, BEL) who published evidence-based guidelines to manage LBP and radicular pain (Van Wambeke et al. 2017), leads to exclusion from treatment within the study.
  • Generalized musculoskeletal pain (based on fibromyalgia criteria) (Galvez-Sánchez and Reyes del Paso 2020).

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • REVAL Faculty of Rehabilitation Sciences

    Diepenbeek, 3590

Other trials in Belgium

About this study

Official title: Direct Access to Physiotherapy for Acute Low Back Pain: a Pragmatic Pilot Trial

Previous research showed that direct access to physiotherapy, and the associated early physiotherapeutic treatment of patients with low back pain (LBP), results in improved clinical outcomes, as well as reduced health-related costs. However, despite these results, the effectiveness of direct access to physiotherapy and its impact on costs has never been investigated in Belgium. Therefore, the goal of this study is to compare the (cost-)effectiveness of direct access to physiotherapy compared to usual care by the general practitioner (GP) for patients with acute LBP.

In this study, 600 patients with acute LBP (lasting >24 hours and <6 weeks) will be divided into two groups (Dutch-speaking: n=2x150; French-speaking n= 2x150). One group will receive treatment through direct access to the physiotherapist, without prescription by a GP. The other group will follow the traditional care pathway through the GP. Th effects on pain, disability and cost-effectiveness will be analysed using questionnaires obtained before and at the end of treatment, after 3 months, after one and after two years. Primary outcomes include pain and disability. Secondary outcomes include clinical outcomes, beliefs related to LBP, quality of life, patient satisfaction, but also direct health care costs, health care resource use, as well as absenteeism and productivity loss.

The results of this study will answer the question whether direct access to physiotherapy is (cost)effective for acute LBP. In the long term, these results might be used to optimize the care pathway in Belgium for patients with acute low back pain.

Being tested
Direct access physiotherapy for acute low back pain, Usual care for acute low back pain
Keywords
Direct access
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Direct access physiotherapy for acute low back painOther

    Interventions include physiotherapeutic treatment, without prescription of the general practitioner, for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.

  • Usual care for acute low back painOther

    Interventions include standard of care by the general practitioner for low back pain according to current biopsychosocial national (KCE - Belgium) and international (NICE) guidelines.

Study groups in NCT05215093
Study groupRoleWhat they receive
Direct physiotherapy pathwayExperimentalPeople with acute low back pain will directly go to a physiotherapist, who will treat the patient without prescription of the general practitioner.
Receives: Other: Direct access physiotherapy for acute low back pain
Usual care pathwayActive comparatorPeople with low back pain will receive usual care by the general practitioner (with or without referral to physiotherapy).
Receives: Other: Usual care for acute low back pain

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in pain intensity

    Numeric Rating Scale

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  2. Changes in pain location and extent

    Pain Diagram of Margolis

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  3. Changes in disability

    Oswestry Disability Index

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

Secondary outcomes (5)
  1. Cost-effectiveness of the provided treatment (direct physiotherapy access vs usual care for acute low back pain)

    Costs of low back pain and its treatment in terms of medical and societal costs

    Measured: Up to 2 years after enrollment

  2. Changes in beliefs and cognitions related to low back

    Back Pain Attitude Questionnaire (Back-PAQ)

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  3. Changes in patient satisfaction

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  4. Changes in quality of life

    EQ-5D

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

  5. Amount of / coping with flare-ups during follow-up

    Measured: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Jan 2022
  2. Study start1 Dec 2022
  3. Primary completion1 Sep 2026
  4. Study completion1 Sep 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05215093
Sponsor's protocol ID
CME2021/066
Status last verified
Sep 2026
First submitted
13 Dec 2021
Last updated
17 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Direct access physiotherapy for acute low back pain in people with Low Back Pain and Physiotherapy, run by Hasselt University at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in pain intensity (time frame: Immediately before, during the first 6 weeks and immediately after intervention and at 3 months, 1 and 2 years after enrollment). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in